Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rumor Mill: Is Google working on contact lenses for the blind?
Mass Device
Wednesday, April 16, 2014 - 10:59am
tags:
Google, devices, blindness
Zalicus and Epirus Announce Merger Agreement
Yahoo
Wednesday, April 16, 2014 - 10:57am
tags:
M&A, Zalicus, Epirius
Why Lpath Could Rise 300%
24/7WallStreet
Wednesday, April 16, 2014 - 10:55am
tags:
Lpath, wet age-related macular degeneration, iSONEP
Tale of two eye drugs plays out in Medicare's doctor reimbursements
Tampa Bay News, FL
Wednesday, April 16, 2014 - 10:43am
tags:
Medicare, physicians, off-label, Lucentis, Avastin
Cleveland BioLabs Inc completion of Phase 1 Study of CBL0102
Reuters
Wednesday, April 16, 2014 - 10:26am
tags:
Cleveland BioLabs, CBL0102, cancer
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wednesday, April 16, 2014 - 10:22am
tags:
MannKind, Alkermes, Gilead Sciences, ledipasvir, AbbVie, Afrezza, aripiprazole lauroxil, Pharmacyclics, Imbruvica
Gilead: This Baby Has Been Thrown Away With The Bathwater
Seeking Alpha
Wednesday, April 16, 2014 - 10:19am
tags:
Gilead Sciences, Sovaldi
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Seeking Alpha
Wednesday, April 16, 2014 - 9:37am
tags:
Lyxumia, GLP-1 agonist, Sanofi, Novo Nordisk, diabetes, Victoza
Roche adds a slate of PhIII schizophrenia trial failures to bitopertin's obituary
Fierce Biotech
Wednesday, April 16, 2014 - 9:10am
tags:
bitopertin, Roche, schizophrenia
FDA Formally Withdraws Approval for Second Generic Version of Popular Antidepressant
Regulatory Focus
Wednesday, April 16, 2014 - 9:08am
tags:
FDA, generics, GSK, antidepressants, Wellbutrin XL, Watson Pharmaceuticals
Abbott First-Quarter Profit Beats Estimates on Diagnostic Tests
Bloomberg
Wednesday, April 16, 2014 - 9:07am
tags:
Abbott Labs, earnings
Here’s Why Johnson & Johnson Had a Crazy Good First Quarter
Wall St Cheat Sheet
Wednesday, April 16, 2014 - 8:51am
tags:
JNJ, earnings
FDA OKs new generation Boston Scientific heart pacing devices
Yahoo/Reuters
Wednesday, April 16, 2014 - 8:40am
tags:
Implantable cardioverter defibrillators, arrhythmias, Boston Scientific, devices, FDA, Dynagen X4, Inogen Mini, Dynagen Mini, Inogen X4
Zogenix Wins Order Blocking Massachusetts Ban on Painkiller
Bloomberg
Wednesday, April 16, 2014 - 8:37am
tags:
Zogenix, Massachusetts, Zohydro
Reckitt leans towards pharmaceuticals spin-off
Yahoo/Reuters
Wednesday, April 16, 2014 - 8:35am
tags:
spinoffs, Reckitt Benckiser
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tuesday, April 15, 2014 - 4:49pm
tags:
FDA, Eli Lilly, Boehringer Ingelheim, Trajenta, empagliflozin, diabetes, type 2 diabetes
Will St. Jude Medical (STJ) Surprise This Earnings Season?
Yahoo/Zacks.com
Tuesday, April 15, 2014 - 4:48pm
tags:
devices, earnings, St. Jude Medical
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
Motley Fool
Tuesday, April 15, 2014 - 1:50pm
tags:
Puma Biotechnology, Macrogenics, neratinib, Aratana, MGD007
Teva announces launch of generic Lunesta tablets in U.S.
Yahoo/Fly on the Wall
Tuesday, April 15, 2014 - 1:48pm
tags:
Lunesta, insomnia, generics, Teva Pharmaceuticals, Sunovion
Report: US prescription spending rises 3.2 pct in 2013, as prices climb, generic impact wanes
Yahoo/AP
Tuesday, April 15, 2014 - 1:47pm
tags:
prescription data, drug spending, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.